Related Experiment Video
Updated: Aug 16, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
The Association between Vitamin D Levels and Thrombus Burden in Patients with ST-Elevation Myocardial Infarction
Faysal Şaylık1, Murat Selçuk2, Tayyar Akbulut1
1Van Training and Research Hospital, Health Sciences University, Van, Turkey.
Insights
Low vitamin D levels are linked to high thrombus burden in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Vitamin D deficiency independently predicts this condition, impacting treatment outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Vascular Biology
Background:
- Predicting high thrombus burden (HTB) before primary percutaneous coronary intervention (PCI) is critical for managing ST-elevation myocardial infarction (STEMI).
- The role of vitamin D levels as a potential predictor of HTB in STEMI patients requires further investigation.
Purpose of the Study:
- To investigate the association between vitamin D levels and high thrombus burden (HTB) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary PCI.
- To determine if vitamin D levels can serve as an independent predictor of HTB in this patient population.
Main Methods:
- A prospective, observational study involving 257 STEMI patients undergoing primary PCI.
- Patients were categorized into high thrombus burden (HTB) and low thrombus burden (LTB) groups based on thrombus burden grade.
- Demographic, laboratory, and angiographic features, including vitamin D levels, were compared between the groups.
Main Results:
- Patients with HTB exhibited significantly lower vitamin D levels (8.0 ng/mL) compared to those with LTB (17.9 ng/mL).
- Low vitamin D levels were associated with poorer post-PCI outcomes, including reduced TIMI flow, TIMI myocardial perfusion grade, and ST resolution.
- Multivariable analysis identified vitamin D as an independent predictor of HTB (OR: 0.76, 95% CI: 0.70-0.82; P<0.001).
Conclusions:
- Vitamin D levels are an independent predictor of high thrombus burden in STEMI patients treated with primary PCI.
- A vitamin D level >17.6 ng/mL was identified as an optimal threshold for predicting HTB, with high sensitivity and specificity.
Abstract:
Background: In current practice, establishing the potential predictors of high thrombus burden (HTB) before primary percutaneous coronary intervention (PCI) is crucial for its management. In this research, we aimed to investigate the association between vitamin D levels and HTB in patients with ST-elevation myocardial infarction (STEMI). Methods: This prospective, observational study was conducted on 257 STEMI patients undergoing primary PCI in Van Education and Research Hospital between March 2020 and March 2021. The thrombus burden grade was determined for each subject. The study population was divided into 2 groups: patients with HTB and those with low thrombus burden (LTB) based on the thrombus burden grade. Demographic, laboratory, and angiographic features were compared between the groups. Results: In total, 154 patients (mean age±SD=63.42±11.53 y, 65.6% male) had HTB and 103 patients had LTB (mean age±SD=61.50±10.23 y, 70.9% male). The patients stratified into the HTB group had lower vitamin D levels than those in the LTB group (8.0 ng/mL vs 17.9 ng/mL, respectively; P<0.001). The patients with HTB and low vitamin D levels had lower post-PCI thrombolysis in myocardial infarction (TIMI) flow, TIMI myocardial perfusion grade, and post-PCI ST resolution. In a multivariable analysis, vitamin D was an independent predictor of HTB among the STEMI patients (OR: 0.76, 95%CI: 0.70-0.82; P<0.001). The ideal value of vitamin D to predict HTB was >17.6 ng/mL with a sensitivity of 81.8% and a specificity of 90.3%. Conclusion: The study results showed that vitamin D levels were an independent predictor of HTB in STEMI patients treated by primary PCI.
More Related Videos
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction